Tesla
TSLA
Advanced Micro Devices
AMD
Meta Platforms
META
Amazon
AMZN
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 8.165
- +0.065+0.80%
Trading Mar 24 10:31 ET
501.99MMarket Cap-1.24P/E (TTM)
8.255High8.130Low252.73KVolume8.150Open8.100Pre Close2.07MTurnover0.47%Turnover RatioLossP/E (Static)61.48MShares18.76052wk High1.08P/B442.75MFloat Cap4.62052wk Low--Dividend TTM54.23MShs Float195.970Historical High--Div YieldTTM1.54%Amplitude4.620Historical Low8.189Avg Price1Lot Size
Sage Therapeutics Key Stats
EPS
According to the latest financial report of Sage Therapeutics, the latest earnings per share (TTM) for the company is -1.56. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Sage Therapeutics's free cash flow? The latest report shows it as -66.56M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sage Therapeutics shows that the company's current ratio is 7.42, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sage Therapeutics, the quick ratio is 7.17, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sage Therapeutics? The latest ROE figure is -18.84%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sage Therapeutics, the total asset return on investment (ROA) is -16.38%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sage Therapeutics's latest financial report to see how their gross margin is doing - currently at 88.38%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sage Therapeutics, the net profit margin is -747.33%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.